|
| Case analysis of the treatment of coronary heart disease combined with hemophilia by Chinese medicine master Professor WENG Weiliang |
| Hits 446 Download times 565 Received:September 10, 2023 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2023.11.02 |
| Key Words
coronary heart disease;hemophilia;three-branch lesion;benefitting qi and invigorating blood;WENG Weiliang |
| Author Name | Affiliation | E-mail | | ZHAO Mengjie | Xiyuan Hospital, China Academy of Chinese Medicine Sciences, Beijing 100091, China
NMPA Key Laboratory for Clinical Research and Evaluation of Traditional Chinese Medicine, Xiyuan Hospital, China Academy of Chinese Medicine Sciences, Beijing 100091, China
National Clinical Research Center for Chinese Medicine Cardiology, Beijing 100091, China | | | WANG Xujie | Xiyuan Hospital, China Academy of Chinese Medicine Sciences, Beijing 100091, China | | | ZHANG Wantong | Xiyuan Hospital, China Academy of Chinese Medicine Sciences, Beijing 100091, China
NMPA Key Laboratory for Clinical Research and Evaluation of Traditional Chinese Medicine, Xiyuan Hospital, China Academy of Chinese Medicine Sciences, Beijing 100091, China
National Clinical Research Center for Chinese Medicine Cardiology, Beijing 100091, China | wantong_zhang@hotmail.com | | LU Fang | Xiyuan Hospital, China Academy of Chinese Medicine Sciences, Beijing 100091, China
NMPA Key Laboratory for Clinical Research and Evaluation of Traditional Chinese Medicine, Xiyuan Hospital, China Academy of Chinese Medicine Sciences, Beijing 100091, China
National Clinical Research Center for Chinese Medicine Cardiology, Beijing 100091, China | deerfang@126.com | | WENG Weiliang | Xiyuan Hospital, China Academy of Chinese Medicine Sciences, Beijing 100091, China
NMPA Key Laboratory for Clinical Research and Evaluation of Traditional Chinese Medicine, Xiyuan Hospital, China Academy of Chinese Medicine Sciences, Beijing 100091, China
National Clinical Research Center for Chinese Medicine Cardiology, Beijing 100091, China | |
|
| Abstract
|
| Coronary heart disease(CHD) combined with hemophilia is a difficult-to-treat cardiovascular disease. The pathogenesis of CHD in patients with hemophilia is still unclear. Pharmacological and surgical treatment of CHD has dramatically increased the risk of bleeding in patients with hemophilia, which has bleeding characteristics, leading to significant challenges in treating such patients. Professor WENG Weiliang has applied blood-activating drugs flexibly for such patients with remarkable efficacy. After treatment, the degree of coronary stenosis and angina symptoms were significantly reduced, and the quality of life was improved considerably without bleeding or cardiovascular adverse events. In this paper, we analyze a case of Professor WENG's treatment of CHD combined with hemophilia. In the early stage of treatment of this case, the primary treatment was to benefit qi, nourish blood, and activate blood to prevent bleeding from activated blood. In the later stage of treatment, the main focus was to invigorate blood circulation and remove blood stasis, with the addition of blood-breaking drugs to increase the power of removing blood stasis. At the same time, the emotional management and seasonal medication of the patient with the complex disease were emphasized, and the overall treatment process revitalized the Blood without bleeding. In this study, we explored Professor WENG Weiliang's identification ideas, treatment selection, and medication characteristics of CHD combined with hemophilia to provide thoughts and references for the Chinese medicine treatment of this disease. |
|
|
|
|
|
|
|
